Advertisement

Rivoceranib

Various toxicities following off-label use: case report

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Reference

    1. Cheng L, et al. Initial therapy of advanced anaplastic thyroid cancer via targeting VEGFR-2: A case report. OncoTargets and Therapy 12: 10495-10500, 2019. Available from: URL: http://doi.org/10.2147/OTT.S223727

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Rivoceranib. Reactions Weekly 1786, 149 (2020). https://doi.org/10.1007/s40278-020-73623-2

    Download citation